A recent study conducted on mice has provided promising insights into a potential alternative treatm...

Roche Pharma India Ltd. has launched Vabysmo (faricimab) for the treatment of age-related macular de...

Ocugen has announced that the second phase of the OCU410 ArMaDa clinical trial will continue followi...

Genentech announced the reintroduction of Susvimo (ranibizumab injection) 100 mg/mL for intravitreal...

Outlook Therapeutics announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA...

Regeneron Pharmaceuticals announced that The Lancet has published the one-year results of the pivota...

Formycon AG and MS Pharma announced that their product, Ravegza (FYB201), a biosimilar to Lucentis (...

The U.S. Food and Drug Administration (FDA) has accepted a revised supplemental New Drug Application...

In an innovative stride toward combating age-related macular degeneration (AMD), Oculogenex, Inc. ha...

NexThera has officially submitted a Phase 1/2a Investigational New Drug (IND) application to the U.S...